Dynatronics (NASDAQ:DYNT) Posts Earnings Results

Dynatronics (NASDAQ:DYNT – Get Rating) announced its earnings results on Thursday. The medical equipment provider reported ($0.09) EPS for the quarter, meeting analysts’ consensus estimates of ($0.09), MarketWatch Earnings reports. Dynatronics had a return on equity of 12.52% and a net margin of 4.50%. Dynatronics updated its Q4 2022 guidance to EPS and its FY 2022 guidance to EPS.

DYNT opened at $0.62 on Friday. The business’s 50-day simple moving average is $0.70 and its 200-day simple moving average is $0.92. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 2.38. Dynatronics has a one year low of $0.43 and a one year high of $1.79. The stock has a market capitalization of $11.20 million, a P/E ratio of -62,380.00 and a beta of -0.01.

Several equities research analysts recently commented on the company. Zacks Investment Research raised Dynatronics from a “sell” rating to a “hold” rating in a report on Wednesday, April 13th. Roth Capital reissued a “buy” rating on shares of Dynatronics in a research note on Thursday, February 17th. StockNews.com started coverage on Dynatronics in a research note on Friday. They set a “hold” rating for the company. Finally, TheStreet cut Dynatronics from a “c-” rating to a “d+” rating in a research note on Friday, February 11th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $2.13.

Several institutional investors and hedge funds have recently bought and sold shares of DYNT. Renaissance Technologies LLC increased its position in shares of Dynatronics by 36.8% during the fourth quarter. Renaissance Technologies LLC now owns 1,096,365 shares of the medical equipment provider’s stock worth $1,096,000 after purchasing an additional 295,200 shares in the last quarter. Millennium Management LLC acquired a new stake in shares of Dynatronics during the third quarter worth about $120,000. Goldman Sachs Group Inc. acquired a new stake in shares of Dynatronics during the third quarter worth about $56,000. Finally, Citadel Advisors LLC acquired a new position in Dynatronics in the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 19.46% of the company’s stock.

Dynatronics Company Profile (Get Rating)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.

See Also